-transparent.png){kind=logo}
Retrospectively, an efficacy of the two main variants of the primary combined therapy for serous cystadenocarcinoma was estimated: "surgery+chemotherapy" (552 patients) and "chemotherapy+surgery" (253 patients). Both variants resulted in rather high incidence (83.5% and 81.3%) of the clinical remission, but its duration was 14.4 months in the first group, and 7.6 months in the second. Also, there was some difference in the remote results of the treatment. It is concluded that there should be an individual approach to selecting the first step of the treatment taking account of the peculiarities of the organism and a course of the tumor process.
Related Publications
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
March 1949,
Annals of surgery,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
January 1964,
Akusherstvo i ginekologiia,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
December 1979,
Akusherstvo i ginekologiia,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
January 1953,
Acta - Unio Internationalis Contra Cancrum,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
November 1973,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
October 1964,
Dermatologische Wochenschrift,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
October 1969,
Sanfujinka no jissai. Practice of gynecology and obstetrics,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
January 1999,
Tumori,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
January 1989,
Voprosy onkologii,
I D Nechaeva, and
D G Kotova, and
V L Vinokurov, and
G P Loskutova, and
M A Livshits
January 1969,
Oncology,
